Interleukin-15 affects patient survival through natural killer cell recovery after autologous hematopoietic stem cell transplantation for non-hodgkin lymphomas

Clinical and Developmental Immunology

Volumn 2010, Issue , 2010, Pages

  Porrata, Luis F ^a   Inwards, David J ^a   Micallef, Ivana N ^a   Johnston, Patrick B ^a   Ansell, Stephen M ^a   Hogan, William J ^a   Markovic, Svetomir N ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; ETOPOSIDE; FIBROBLAST GROWTH FACTOR; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MELPHALAN; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; AUTOTRANSPLANTATION; BLOOD; CELL SEPARATION; DISEASE FREE SURVIVAL; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; CELL SEPARATION; DISEASE-FREE SURVIVAL; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTERLEUKIN-15; KAPLAN-MEIERS ESTIMATE; KILLER CELLS, NATURAL; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROGNOSIS; TRANSPLANTATION, AUTOLOGOUS; YOUNG ADULT;

EID: 77952479517     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2010/914945     Document Type: Article

References (32)

1. Porrata L. F., Gertz M. A., Inwards D. J., Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma Blood 2001 98 3 579 585
2. Porrata L. F., Inwards D. J., Micallef I. N., Ansell S. M., Geyer S. M., Markovic S. N., Early lymphocyte recovery post-autologous haematopoietic stem cell transplantation is associated with better survival in Hodgkins disease British Journal of Haematology 2002 117 3 629 633
3. Porrata L. F., Litzow M. R., Tefferi A., Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia Leukemia 2002 16 7 1311 1318
4. Joao C., Porrata L. F., Inwards D. J., Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma Bone Marrow Transplantation 2006 37 9 865 871
5. Kim H., Sohn H.-J., Kim S., Lee J.-S., Kim W.-K., Suh C., Early lymphocyte recovery predicts longer survival after autologous peripheral blood stem cell transplantation in multiple myeloma Bone Marrow Transplantation 2006 37 11 1037 1042
6. Boulassel M. R., Herr A. L., Deb Edwardes M. D., Early lymphocyte recovery following autologous peripheral stem cell transplantation is associated with better survival in younger patients with lymphoproliferative disorders Hematology 2006 11 3 165 170
7. Kim H., Sohn H.-J., Kim S.-E., Lymphocyte recovery as a positive predictor of prolonged survival after autologous peripheral blood stem cell transplantation in T-cell non-Hodgkins lymphoma Bone Marrow Transplantation 2004 34 1 43 49
8. Gordan L. N., Sugrue M. W., Lynch J. W., Williams K. D., Khan S. A., Moreb J. S., Correlation of early lymphocyte recovery and progression-free survival after autologous stem-cell transplant in patients with Hodgkins and non-Hodgkins lymphoma Bone Marrow Transplantation 2003 31 11 1009 1013
9. Porrata L. F., Gertz M. A., Litzow M. R., Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis Clinical Cancer Research 2005 11 3 1210 1218
10. Ferrandina G., Pierelli L., Perillo A., Lymphocyte recovery in advanced ovarian cancer patients after high-dose chemotherapy and peripheral blood stem cell plus growth factor support: clinical implications Clinical Cancer Research 2003 9 1 195 200
11. Nieto Y., Shpall E. J., McNiece I. K., Prognostic analysis of early lymphocyte recovery in patients with advanced breast cancer receiving high-dose chemotherapy with an autologous hematopoietic progenitor cell transplant Clinical Cancer Research 2004 10 15 5076 5086 (Pubitemid 39099782)
12. Porrata L. F., Ingle J. N., Litzow M. R., Geyer S., Markovic S. N., Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer Bone Marrow Transplantation 2001 28 9 865 871
13. Porrata L. F., Inwards D. J., Ansell S. M., Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective study Biology of Blood and Marrow Transplantation 2008 14 7 807 816
14. Porrata L. F., Lotzow M. R., Inwards D. J., Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkins lymphoma Bone Marrow Transplantation 2004 33 3 291 298
15. Porrata L. F., Gertz M. A., Geyer S. M., The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma Leukemia 2004 18 6 1085 1092
16. Hiwase D. K., Hiwase S., Bailey M., Bollard G., Schwarer A. P., Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma Biology of Blood and Marrow Transplantation 2008 14 1 116 124
17. Aqui N. A., June C. H., Post-transplant adoptive T-cell immunotherapy Best Practice and Research: Clinical Haematology 2008 21 3 503 519
18. Katipamula R., Porrata L. F., Gastineau D. A., Apheresis instrument settings influence infused absolute lymphocyte count affecting survival following autologous peripheral hematopoietic stem cell transplantation in non-Hodgkins lymphoma: the need to optimize instrument setting and define a lymphocyte collection target Bone Marrow Transplantation 2006 37 9 811 817
19. Cheson B. D., Horning S. J., Coiffier B., Report of an international workshop to standardize response criteria for non-Hodgkins lymphomas Journal of Clinical Oncology 1999 17 4 1244 1253
20. Kaplan E., Meier P., Nonparametric estimation from incomplete observations Journal of the American Statistical Association 1958 53 457 481
21. Cox D., Regression models and life tables Journal of the Royal Statistical Society B 1972 34 187 202
22. Porrata L. F., Inwards D. J., Lacy M. Q., Markovic S. N., Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-in autologous stem cell transplantation Bone Marrow Transplantation 2001 28 7 673 680
23. Baiocchi G., Scambia G., Benedetti P., Autologous stem cell transplantation: sequential production of hematopoietic cytokines underlying granulocyte recovery Cancer Research 1993 53 6 1297 1303
24. Guillaume T., Sekhavat M., Rubinstein D. B., Hamdan O., Leblanc P., Symann M. L., Defective cytokine production following autologous stem cell transplantation for solid tumors and hematologic malignancies regardless of bone marrow or peripheral origin and lack of evidence for a role for interleukin-10 in delayed immune reconstitution Cancer Research 1994 54 14 3800 3807
25. Ma A., Koka R., Burkett P., Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis Annual Review of Immunology 2006 24 657 679
26. Carson W. E., Fehniger T. A., Haldar S., A potential role for interleukin-15 in the regulation of human natural killer cell survival Journal of Clinical Investigation 1997 99 5 937 943
27. Boyiadzis M., Memon S., Carson J., Up-regulation of NK cell activating receptors following allogeneic hematopoietic stem cell transplantation under a lymphodepleting reduced intensity regimen is associated with elevated IL-15 levels Biology of Blood and Marrow Transplantation 2008 14 3 290 300
28. Waldmann T. A., The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design Nature Reviews Immunology 2006 6 8 595 601
29. Dean R., Masci P., Pohlman B., Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival Bone Marrow Transplantation 2005 36 12 1049 1052
30. Doherty T. M., Seder R. A., Sher A., Induction and regulation of IL-15 expression in murine macrophages Journal of Immunology 1996 156 2 735 741
31. Neely G. G., Robbins S. M., Amankwah E. K., Lipopolysaccharide-stimulated or granulocyte-macrophage colony-stimulating factor-stimulated monocytes rapidly express biologically active IL-15 on their cell surface independent of new protein synthesis Journal of Immunology 2001 167 9 5011 5017
32. Joao C., Porrata L. F., Burgstaler E. A., Immunologic autograft engineering by manipulation of apheresis machine collection settings Biology of Blood and Marrow Transplantation 2006 12 2, supplement 1 105. abstract 298